OVA Peptide (257-264) TFA is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
OVA Peptide (257-264) TFA is a synthetic peptide fragment derived from the ovalbumin protein, specifically encompassing amino acid residues 257 to 264. As a well-characterized epitope, this peptide is widely recognized for its immunological significance, particularly in the context of T cell recognition and antigen presentation studies. The TFA (trifluoroacetate) salt form ensures solubility and handling convenience for laboratory applications. Its precise sequence and defined structure make it a valuable tool in immunological research, peptide-MHC interaction analyses, and the development of antigen-specific assays. Researchers utilize this peptide to dissect cellular immune responses and to probe the molecular mechanisms underlying antigen processing.
Epitope Mapping: OVA Peptide (257-264) serves as a model antigenic determinant for mapping T cell epitopes and studying the specificity of T cell receptors (TCRs). By incorporating this peptide into in vitro assays, scientists can elucidate the interactions between antigen-presenting cells and T lymphocytes, providing insights into the mechanisms of immune recognition. Its defined sequence facilitates the detailed analysis of peptide-MHC complex formation and the subsequent activation of antigen-specific CD8+ T cells.
Immunogenicity Assessment: In experimental immunology, this peptide is frequently employed to evaluate immune responses in various animal models. It enables the assessment of cytotoxic T lymphocyte (CTL) activity, cytokine production, and memory T cell generation following immunization or infection. By using the OVA 257-264 fragment, researchers can standardize their protocols and compare immunogenicity across different experimental conditions, supporting the development of vaccines and immunotherapeutic strategies at the preclinical level.
Peptide-MHC Binding Studies: The defined nature of this peptide allows for precise investigations into major histocompatibility complex (MHC) class I binding dynamics. It is commonly used in binding affinity assays to characterize the interaction between peptide ligands and MHC molecules, providing quantitative and qualitative data on peptide presentation. Such studies are foundational for understanding the principles of antigen processing and for the rational design of peptide-based immunomodulators.
T Cell Functional Assays: OVA Peptide (257-264) is integral to the design of functional assays that monitor T cell activation, proliferation, and effector functions. By introducing this peptide into co-culture systems or ex vivo assays, investigators can specifically stimulate antigen-experienced T cells, measure their functional responses, and dissect the signaling pathways involved in immune activation. These applications are essential for advancing knowledge in cellular immunology and for validating new immunological reagents or models.
Quality Control in Immunoassays: The peptide is often utilized as a positive control in various immunoassays, including ELISPOT, intracellular cytokine staining, and tetramer staining protocols. Its consistent immunogenic properties make it a reliable benchmark for assay validation, ensuring reproducibility and accuracy in experimental workflows. By incorporating this well-characterized fragment, laboratories can confidently assess assay performance and maintain rigorous quality standards in immunological research.
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More